|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J cancer. 127:2893–2917. 2010.
|
|
2
|
Qian BY, Hem M, Dong SF, Wang JF and Chen
KX: Incidence and mortality of thyroid cancers in Tianjin from 1981
to 2001. Zhonghua Nei Fen Mi Dai Xie Za Zhi. 5:432–434. 2005.(In
Chinese).
|
|
3
|
Perri F, Lorenzo GD, Scarpati GD and
Buonerba C: Anaplastic thyroid carcinoma: A comprehensive review of
current and future therapeutic options. World J Clin Oncol.
2:150–157. 2011.
|
|
4
|
Hunt JP, Buchmann LO, Wang L and Abraham
D: An analysis of factors predicting lateral cervical nodal
metastases in papillary carcinoma of the thyroid. Arch Otolaryngol
Head Neck Surg. 137:1141–1145. 2011.
|
|
5
|
Onoda N, Ishikawa T, Kawajiri H, Takashima
T and Hirakawa K: Pattern of initial metastasis in the cervical
lymph node from papillary thyroid carcinoma. Surg Today.
43:178–184. 2013.
|
|
6
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
|
|
7
|
Ambros V: The evolution of our thinking
about microRNAs. Nat Med. 14:1036–1040. 2008.
|
|
8
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
|
|
9
|
Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT,
Xia YJ, Ye ZY and Tao HQ: MicroRNA-101 is down-regulated in gastric
cancer and involved in cell migration and invasion. Eur J Cancer.
46:2295–2303. 2010.
|
|
10
|
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y
and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular
carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer
Res. 69:1135–1142. 2009.
|
|
11
|
Li S, Fu H, Wang Y, Tie Y, Xing R, Zhu J,
Sun Z, Wei L and Zheng X: MicroRNA-101 regulates expression of the
v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene
in human hepatocellular carcinoma. Hepatology. 49:1194–1202.
2009.
|
|
12
|
Wang R, Wang HB, Hao CJ, Cui Y, Han XC, Hu
Y, Li FF, Xia HF and Ma X: MiR-101 is involved in human breast
carcinogenesis by targeting Stathmin1. PLoS One. 7:e461732012.
|
|
13
|
Hao Y, Gu X, Zhao Y, Greene S, Sha W,
Smoot DT, Califano J, Wu TC and Pang X: Enforced expression of
miR-101 inhibits prostate cancer cell growth by modulating the
COX-2 pathway in vivo. Cancer Prev Res (Phila). 4:1073–1083.
2011.
|
|
14
|
Hiroki E, Akahira J, Suzuki F, Nagase S,
Ito K, Suzuki T, Sasano H and Yaegashi N: Changes in microRNA
expression levels correlate with clinicopathological features and
prognoses in endometrial serous adenocarcinomas. Cancer Sci.
101:241–249. 2010.
|
|
15
|
Zhang J, Socolovsky M, Gross AW and Lodish
HF: Role of Ras signaling in erythroid differentiation of mouse
fetal liver cells: functional analysis by a flow cytometry-based
novel culture system. Blood. 102:3938–3946. 2003.
|
|
16
|
He L and Hannon GJ: MicroRNAs small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531.
2004.
|
|
17
|
Didsbury J, Weber RF, Bokoch GM, Evans T
and Snyderman R: rac, a novel ras-related family of proteins that
are botulinum toxin substrates. J Biol Chem. 264:16378–16382.
1989.
|
|
18
|
del Pozo MA, Price LS, Alderson NB, Ren XD
and Schwartz MA: Adhesion to the extracellular matrix regulates the
coupling of the small GTPase Rac to its effector PAK. EMBO J.
19:2008–2014. 2000.
|
|
19
|
Chung CY, Lee S, Briscoe C, Ellsworth C
and Firtel RA: Role of Rac in controlling the actin cytoskeleton
and chemotaxis in motile cells. Proc Natl Acad Sci USA.
97:5225–5230. 2000.
|
|
20
|
Zhao SY, Sun Y, Lai ZS, Nan QZ, Li K and
Zhang ZS: Inhibition of migration and invasion of colorectal cancer
cells via deletion of Rac1 with RNA interference. Mol Cell Biochem.
322:179–184. 2009.
|
|
21
|
Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY,
Hu HZ, Wu YQ, Song J, Yan J and Wu LJ: Silencing of Rac1 modifies
lung cancer cell migration, invasion and actin cytoskeleton
rearrangements and enhances chemosensitivity to antitumor drugs.
Int J Mol Med. 28:769–776. 2011.
|
|
22
|
Zhen C, Chen L, Zhao Q, Liang B, Gu YX,
Bai ZF, Wang K, Xu X, Han QY, Fang DF, et al: Gankyrin promotes
breast cancer cell metastasis by regulating Rac1 activity.
Oncogene. 32:3452–3460. 2013.
|
|
23
|
Hernández E, De La Mota-Peynado A,
Dharmawardhane S and Vlaar CP: Novel inhibitors of Rac1 in
metastatic breast cancer. P R Health Sci J. 29:348–356. 2010.
|
|
24
|
Kamai T, Shirataki H, Nakanishi K, Furuya
N, Kambara T, Abe H, Oyama T and Yoshida K: Increased Rac1 activity
and Pak1 overexpression are associated with lymphovascular invasion
and lymph node metastasis of upper urinary tract cancer. BMC
Cancer. 10:1642010.
|
|
25
|
Yap LF, Jenei V, Robinson CM, Moutasim K,
Benn TM, Threadgold SP, Lopes V, Wei W, Thomas GJ and Paterson IC:
Upregulation of Eps8 in oral squamous cell carcinoma promotes cell
migration and invasion through integrin-dependent Rac1 activation.
Oncogene. 28:2524–2534. 2009.
|
|
26
|
Wang P, Chen L, Zhang J, Chen H, Fan J,
Wang K, Luo J, Chen Z, Meng Z and Liu L: Methylation-mediated
silencing of the miR-124 genes facilitates pancreatic cancer
progression and metastasis by targeting Rac1. Oncogene. 23:514–524.
2014.
|
|
27
|
Imam JS, Plyler JR, Bansal H, Prajapati S,
Bansal S, Rebeles J, Chen HI, Chang YF, Panneerdoss S, Zoghi B, et
al: Genomic loss of tumor suppressor miRNA-204 promotes cancer cell
migration and invasion by activating AKT/mTOR/Rac1 signaling and
actin reorganization. PLoS One. 7:e523972012.
|
|
28
|
Zhou Y, Su J, Shi L, Liao Q and Su Q: DADS
downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling
pathway, inhibiting cell migration and invasion. Oncol Rep.
29:605–612. 2013.
|
|
29
|
Gupta GP and Massagué J: Cancer
metastasis: building a framework. Cell. 127:679–695. 2006.
|
|
30
|
Klein CA: Cancer. The metastasis cascade.
Science. 321:1785–1787. 2008.
|
|
31
|
Sreekumar R, Sayan BS, Mirnezami AH and
Sayan AE: MicroRNA control of invasion and metastasis pathways.
Front Genet. 2:582011.
|
